Aurinia Pharmaceuticals
AUPH
#4822
Rank
NZ$3.62 B
Marketcap
NZ$27.08
Share price
-1.59%
Change (1 day)
-1.11%
Change (1 year)

EPS for Aurinia Pharmaceuticals (AUPH)

EPS in 2026 (TTM): NZ$4.15

According to Aurinia Pharmaceuticals 's latest financial reports the company's current EPS (TTM) is NZ$4.35. In 2025 the company made an earnings per share (EPS) of NZ$3.95 an increase over its 2024 EPS that were of NZ$0.09095.

EPS history for Aurinia Pharmaceuticals from 2017 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$4.155.17%
2025NZ$3.954240%
2024NZ$0.09095
2022NZ-$1.38-46.1%
2021NZ-$2.5663.95%
2020NZ-$1.56-33.85%
2019NZ-$2.3673.33%
2018NZ-$1.36-34.78%
2017NZ-$2.09

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Regeneron Pharmaceuticals
REGN
NZ$85.46 1,865.69%๐Ÿ‡บ๐Ÿ‡ธ USA
Pieris Pharmaceuticals
PIRS
NZ-$32.01-836.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Aeterna Zentaris
AEZS
NZ-$3.73-185.73%๐Ÿ‡บ๐Ÿ‡ธ USA